CURE has an FDA-registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform which includes CUREfilm®, one of the most advanced oral thin films on the market today; CUREpods™ a novel chewable delivery system and other more traditional dose forms that use advanced encapsulation technology. CUREform’s combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients. CURE also holds the NSF® cGMP certification for manufacturing dietary supplements.
CURE’s clinical pipeline includes CUREfilm® Blue (sildenafil to treat erectile dysfunction), and CUREfilm® Canna (THC and CBD) each designed to optimize the pharmacokinetic profile of the medicine.
CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets.
Cure Pharmaceutical Corporation was founded in July 2011 and is a wholly-owned subsidiary of Cure Pharmaceutical Holding Corp, a public company.
1620 Beacon Place
Oxnard, CA 93033
We are positioned to advance numerous therapeutic categories, including pharmaceutical cannabis.
Our Investor Presentation
CURE Pharmaceutical Investor
Video Webcast | Dec. 17 2020
CBD, Cannabis and the Cannabiz
In the news
OXNARD, Calif. - CURE Pharmaceutical Holdings ("CURE" or the "Company") (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. After...
Sera Labs Unveils ImmunD₃™ an Important New Offering to the Nutri-Strips™ Product Line; Launches New Digital E-commerce Website to Amplify Consumer Awareness
Sera Labs Pioneers the Delivery of Next Generation Immune Support in the Continued Battle Against the COVID-19 Pandemic LOS ANGELES & OXNARD, Calif. - According to the National Institute of Health (NIH) more than 50 percent of people worldwide have Vitamin D...
Health, Wellness, CBD and plant-based anti-aging skincare powerhouse, Sera Labs wins Drug Store News' annual Natural Products Award LOS ANGELES & OXNARD, Calif. - The retailers have spoken! Sera Labs, Inc., the wholly owned subsidiary of CURE Pharmaceutical...
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's Chief Executive Officer...
OXNARD, Calif. - CURE Pharmaceutical Holding Corp ("CURE" or the "Company") (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company's...
CURE Pharmaceutical Receives FDA Approval for its IND Application for Erectile Dysfunction Product CUREfilm Blue™
OXNARD, Calif. - CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S....
Board of Directors
Chief Executive Officer, Director
Chief Financial Officer
Chief Strategic Officer and Director; CEO of Wholly owned subsidiary, The Sera Labs
Chief Scientific Officer
Chief Accounting Officer
Chief Business Officer
Vice President of Quality and Compliance Systems
Chairman of the Board
Chief Executive Officer, Director
Chief Strategic Officer and Director, CEO of Wholly owned subsidiary, The Sera Labs.
(805) 410-9962 ext. 4
805 3rd Avenue #1430
New York, NY 10022
10100 Santa Monica Blvd., 8th Fl.
Los Angeles, CA 90067